Part, Chapter, Paragraph
1 II, 5. 3. 5| Prostate-Specific Antigen) testing, which resulted in increased
2 II, 5. 4. 2| diabetes care~Annual HbA1c testing~Annual LDL cholesterol testing~
3 II, 5. 4. 2| testing~Annual LDL cholesterol testing~Annual screening for nephropathy~
4 II, 5. 4. 3| existing recommendations for testing.~LDL cholesterol level >
5 II, 5. 4. 6| of oral glucose tolerance testing for the diagnosis of this
6 II, 5. 4. 8| Should oral glucose tolerance testing be mandatory following acute
7 II, 5. 7. 1| currently underway for further testing the value of these biomarkers
8 II, 5. 9. 4| EXPAH project (htt f) is testing the hypothesis that PAHs
9 II, 5. 11. 3| ESSCA): results of patch testing the standard series, 2004.
10 II, 5. 11. 3| investigation by means of patch testing, a process whereby a standard
11 II, 6. 3. 2| methodology for sensitivity testing is the same in all laboratories
12 II, 6. 3. 3| must be made to increase testing uptake; thus, ECDC has started
13 II, 8. 1. 4| screened with cognitive testing. A first discussion with
14 II, 8. 1. 4| A larger translation and testing is also planned.~On the
15 II, 8. 1. 4| basis of the results of the testing phase, a decision will then
16 II, 8. 2. 1| Doctors may recommend genetic testing for people who have a family
17 II, 8. 2. 2| refractive services for testing; insufficient provision
18 II, 9. 3. 1| recommended for further testing and treatment (Arber, 2006).~ ~
19 II, 9. 3. 2| EURO-PERISTAT group is currently testing the feasibility and quality
20 II, 9. 3. 3| revised, but reliability testing was not undertaken in European
21 III, 10. 2. 1| intensive random breath testing, where police regularly
22 III, 10. 2. 4| harmonisation of genetic testing services in the EU” (Ibarreta
23 III, 10. 2. 4| harmonisation of genetic testing services in the EU, www ~ ~
24 III, 10. 2. 5| an absence of systematic testing, many additional chemicals
25 III, 10. 2. 5| origin are the great gaps in testing chemicals for developmental
26 III, 10. 3. 2| emergency plans (elaboration and testing) and provision of information
27 III, 10. 3. 2| an absence of systematic testing, many additional chemicals
28 III, 10. 3. 2| origin are the great gaps in testing chemicals for developmental
29 III, 10. 4. 2| across the EU to harmonise testing methodology for contaminants.
30 III, 10. 4. 2| Commission but the frequency of testing varies across Member States.
31 III, 10. 4. 2| microorganisms, microbiological testing of finished food products
32 III, 10. 4. 2| supplements, is currently under testing within the framework of
33 III, 10. 4. 2| without any need for further testing. Issues that should be carefully
34 III, 10. 4. 2| purposes (e.g. for field testing), is governed by Directive
35 III, 10. 4. 2| verifications, audits, sampling and testing of samples. Training of
36 III, 10. 4. 2| laboratory capacity for testing and a sufficient number
37 IV, 11. 5. 3| of authorised tests for testing the donors is a binding
38 IV, 12. 2 | intensive random breath testing, where police regularly
39 IV, 12. 10 | for comparative product testing (Stiftung Warentest, see www. –
40 IV, 12. 10 | voluntary counselling and HIV testing services (initiated by Global
